Tuberculosis and leprosy, caused by bacilli from the Mycobacterium tuberculosis complex and M. leprae, respectively, are the two major mycobacterial diseases. Worldwide, 60 million people suffer from active tuberculosis; annually, 10 million new cases arise and 3 million people die. Pathogenic mycobacteria have the ability to survive within host phagocytic cells. The interactions between the host and bacteria result in the pathology of tuberculosis infection. Alternatively, the protection of the host is also dependent on its interactions with mycobacteria.
Identification of the bacterial antigens involved in these interactions with the immune system is essential for understanding the pathogenic mechanisms of mycobacteria and the host immunological response in relation to evolution of the disease. It is also of great importance for improving the methods of mycobacterial disease control through vaccination and immunodiagnosis. The development of a serodiagnostic test that utilizes immunodominant mycobacterial antigens would provide a rapid and economical alternative to the very long and/or expensive existing techniques based on the culture of mycobacteria from clinical isolates or PCR amplification of specific mycobacterial sequences.
Various strategies have been used for identifying mycobacterial antigens. Biochemical tools for fractionating and analyzing bacterial proteins allowed the isolation of antigenic proteins selected by their capacity to elicit B-or T-cell responses (26, 32) . The recent development of molecular genetic methods for mycobacteria (12, 15, 31, 39) allowed the construction of DNA expression libraries of both M. tuberculosis and M. leprae in the gt11 vector and their expression in Escherichia coli. The screening of these recombinant libraries with murine polyclonal and monoclonal antibodies and patient sera led to the identification of numerous antigens (6, 13, 36) . Among the first proteins to be identified in this way was the group of highly conserved heat shock proteins (36, 38) .
The observation in animal models that specific protection against tuberculosis was conferred only by the administration of live M. bovis BCG vaccine, in addition to the fact that mixtures of extracellular proteins induced cell-mediated immune responses and protective immunity in guinea pig and mouse models of tuberculosis (2, 11, 25) , suggested that mycobacterial secreted proteins play a major role in inducing protective immunity. Recently, a genetic methodology for the identification of exported proteins based on phoA gene fusions was adapted for mycobacteria by Lim et al. (24) . It permitted the isolation of M. tuberculosis DNA fragments encoding exported proteins. Among these proteins are the already described 19-kDa lipoprotein (22) and the Erp protein, similar to the M. leprae 28-kDa antigen (3) .
Here, we report the characterization of a new M. tuberculosis exported protein, Des, identified by phoA gene fusion methodology. The des gene, which is conserved among mycobacterial species, encodes an antigenic protein that is highly recognized by human sera from both tuberculosis and leprosy patients but not by sera from tuberculous cattle. The amino acid sequence of the Des protein contains two sets of motifs that are characteristic of the active sites of enzymes from the class II diiron-oxo protein family. The Des protein has significant homologies to soluble stearoyl-acyl carrier protein (ACP) desaturases, which are members of this family.
MATERIALS AND METHODS
Bacteria, media, and growth conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . E. coli DH5␣ and BL21(DE3)(pLysS) cultures were routinely grown in Luria B medium (Difco) at 37°C. Mycobacterium cultures were grown in Middlebrook 7H9 medium (Difco) supplemented with Tween 80 (0.05%), glycerol (0.2%), and ADC (glucose, 0.2%; bovine serum albumin fraction V, 0.5%; and NaCl, 0.085%) at 37°C. Antibiotics were added when required at the following concentrations: ampicillin, 100 g/ml; and kanamycin, 20 g/ml.
Human and cattle sera. Serum specimens from 20 individuals with pulmonary or extrapulmonary tuberculosis (M. tuberculosis infected) were obtained from the Bligny sanatorium (Bligny, France). Six sera from M. bovis-infected human tuberculous patients and 24 sera from BCG-vaccinated patients that suffered from other pathologies were obtained from the Institut Pasteur of Madagascar and the Centre de Biologie Médicale Spécialisée (Institut Pasteur, Paris, France), respectively. All human sera came from adult patients. Sera from seven tuberculous cattle (four experimentally infected with M. bovis and three infected naturally with the same mycobacterium) were obtained from CNEVA (Maison Alfort, France).
Subcloning procedures. Restriction enzymes and T4 DNA ligase were purchased from Gibco/BRL, Boehringer Mannheim, and New England Biolabs. All enzymes were used in accordance with the manufacturers' recommendations. A 1-kb ladder of DNA molecular mass markers was obtained from Gibco/BRL. DNA fragments used in cloning procedures were gel purified with a Geneclean II kit (BIO 101, Inc., La Jolla, Calif.). Cosmids and plasmids were isolated by alkaline lysis (27) . Bacterial strains were transformed by electroporation with a Gene Pulser unit (Bio-Rad Laboratories, Richmond, Calif.).
(Biosys) immunoglobulin G alkaline phosphatase-conjugated secondary antibody diluted 1/2,500 for 30 min at 37°C. The color reaction was performed by the addition of 5-bromo-4-chloro-3-indolylphosphate (0.165 mg/ml) and nitroblue tetrazolium (0.33 mg/ml) as substrates.
ELISA. Human and cattle sera were tested for antibodies against Des by enzyme-linked immunosorbent assay (ELISA). The 96-well microtiter trays (Nunc) were coated with 0.1 g of purified Des protein per well in guanidine hydrochloride buffer A (6 M guanidine hydrochloride, 0.1 M NaH 2 PO 4 , 0.01 M Tris [pH 8]) (1 h at 37°C and 16 h at 4°C). After three washes, wells were saturated with 3% bovine serum albumin in phosphate-buffered saline for 30 min at room temperature. After three washes, sera diluted from 1/50 to 1/3,200 in a buffer containing phosphate-buffered saline, 0.1% Tween 20, and 1% bovine serum albumin were added to wells for 2 h at 37°C. After three washes, wells were treated with goat anti-human immunoglobulin G-alkaline phosphatase conjugate (Promega) diluted 1/4,000 for 1 h at 37°C. Then 4 mg of the substrate p-nitrophenylphosphate per ml was added. After 20 min of incubation at 37°C, plates were read photometrically at a wavelength of 405 nm in a micro-ELISA autoreader (Dynatech, Marnes la Coquette, France).
Statistics. The antibody responses of the sera tested were compared by using the Student t test. A difference with a P value of Ն0.05 was considered insignificant.
Nucleotide sequence accession number. The nucleotide sequence of the des gene has been deposited in the Genome Sequence database under accession no. U49839.
RESULTS
Cloning of the des gene. The construction of a library of fusions of M. tuberculosis genomic DNA to the phoA gene and its expression in M. smegmatis (24) led to the isolation of several PhoA ϩ clones. pExp421 is the plasmid harbored by one of the PhoA ϩ clones selected from this library. The detection of enzymatically active alkaline phosphatase indicated that the pExp421 insert contains functional expression and exportation signals. Restriction analysis showed that pExp421 carries a 1.1-kb insert. Partial determination of its sequence identified a 577-bp open reading frame (ORF), des, fused in frame to the phoA gene and encoding two motifs (of 9 and 14 amino acids) conserved in soluble stearoyl-ACP desaturases (24) .
To isolate the full-length des gene, the M. tuberculosis H37Rv(pYUB18) genomic cosmid library (15) was screened by colony hybridization with the 1.1-kb probe (probe A; Fig. 1 ). Two hybridizing cosmids, C 3 and C 4 , were selected for further isolation of this gene. C 3 and C 4 were cut with several restriction enzymes and subjected to Southern blot analysis with the 1.1-kb fragment as a probe (data not shown). The EcoRV restriction profile revealed a single hybridizing fragment of 4.5 kb, which was subcloned into pBluescript KS Ϫ (Stratagene) to give plasmid pBS-des. Characterization of the des gene. The DNA sequence of the entire des ORF was determined. The des gene covers a 1,017-bp region and encodes a 339-amino-acid protein with a calculated molecular mass of 37 kDa. The ORF starts with a potential ATG start codon at position 549 and ends with a TAG stop codon at position 1565. There is a potential ShineDalgarno motif (GGAGG) at position Ϫ8 upstream of the ATG codon. The GϩC content of this ORF (62%) is consistent with the global GϩC content observed in the mycobacterial genome. The nucleotide and deduced amino acid sequences of the des gene were compared to sequences in databases. They show very high homologies to the sequences of the M. leprae aadX gene, located on cosmid B2266 and deposited in the GenBank database as part of the M. leprae genome sequencing project (GenBank accession no. U15182). Within the coding region, the DNA sequences are 79% identical, while the encoded proteins are 80% identical (88% when conserved residues are included). The des gene also scores significantly against soluble stearoyl-ACP desaturases, with 44% identity at the nucleotide level and 30% identity (51% when conserved residues are included) at the amino acid level to the Oryza sativa stearoyl-ACP desaturase (GenBank accession no. D38753).
Although the detection of a PhoA enzymatic activity in the M. smegmatis clone harboring pExp421 suggests that the Des protein is exported, no structural similarities were found between the Des protein N-terminal amino acids and signal sequences of bacterial exported proteins (14) .
As in the M. leprae genome, a second ORF with high homology to the putative M. leprae ntrB gene (cosmid B2266) is located downstream of the des gene in M. tuberculosis (Fig. 1) . Interestingly, the two ORFs, des and ntrB, are separated in M. tuberculosis by two direct repeats of 66 nucleotides with an overlap of 9 nucleotides. Although M. leprae and M. tuberculosis seem to have the same genomic organization in this part of the chromosome, these repeats are absent from the M. leprae genome.
The Des protein presents the conserved amino acid motifs of class II diiron-oxo proteins. Further analysis of the amino acid sequence of the Des protein revealed the presence of conserved motifs found only in class II diiron-oxo proteins (8) (Fig. 2) . So far, the class II diiron-oxo protein family contains ribonucleotide reductases, hydrocarbon hydroxylases (methane monooxygenase, toluene-4-monooxygenase, and phenol hydroxylase), and soluble ACP desaturases. These enzymes are oxo-bridged diiron cluster (Fe-O-Fe)-containing proteins. They possess in their secondary structure four alpha-helices involved in protein-derived cluster ligands. As revealed by Xray structure studies, in these proteins the diiron axis is oriented parallel to the long axis of the four-helix bundle with ligands arising from four noncontiguous helices, B, C, E, and F. M. tuberculosis Des protein appears to have the same activesite residues as do class II diiron-oxo enzymes. These residues include Glu and His residues (E 107 and H 110 in helix C, E 167 in helix E, and E 197 and H 200 in helix F) that are ligands binding to iron atoms, Asp, Glu, and Arg residues (E 106 and R 109 in helix C and D 196 in helix F) that are involved in a network of hydrogen bonds to the cluster, and Ile and Thr residues that may be part of the O 2 -binding site (T 170 in helix E and I 193 in helix F). Thus, the M. tuberculosis Des protein contains in its primary sequence two conserved (D/E)ENXH motifs separated by 85 amino acids.
In the overall sequence alignment, the Des protein has higher homologies to soluble stearoyl-ACP desaturases than to ribonucleotide reductases or bacterial hydroxylases. At the amino acid level, the Des protein is 30% identical to the O. sativa stearoyl-ACP desaturase, whereas it is only 17% identical to the Methylococcus capsulatus methane monooxygenase (accession no. M58499), 17.5% identical to the Pseudomonas sp. strain CF600 phenol hydroxylase (accession no. M60276), and 17.7% identical to the Epstein-Barr virus ribonucleotide reductase (accession no. V01555). Its homologies to soluble ⌬9 desaturases are mainly in the amino acids within the active sites in helices C, E, and F (Fig. 2) .
Distribution of the des gene in other mycobacterial species. The presence of the des gene in PstI-digested chromosomal DNAs from various mycobacterial strains was analyzed by Southern blotting (Fig. 3) . The probe used (probe B) is a PCR amplification product that corresponds to nucleotides 572 to 1589 (Fig. 1) Furthermore, the probe did not hybridize to chromosomal DNAs of E. coli HB101 and Streptomyces coelicolor in Southern blot experiments carried out under the same conditions (data not shown).
Expression of the des gene in E. coli. In order to overexpress the Des protein, the des gene was subcloned into the bacteriophage T7 promoter-based expression vector pET14b (Novagen) (35) . A PCR amplification product of the des gene (see Materials and Methods) was cloned into the NdeI-BamHI sites of the vector, leading to plasmid pET-des. Upon IPTG induction of E. coli BL21(DE3)(pLysS) cells harboring plasmid pET-des, a protein of about 40 kDa was overproduced. The size of the recombinant protein is in agreement with the calculated molecular mass of the polypeptide deduced from the DNA sequence. The great majority of the overproduced Des protein was present in the insoluble matter of E. coli cells (data not shown). This probably resulted from the formation of inclusion bodies, as the overconcentrated protein precipitated in the E. coli cytoplasm. To dissolve this protein, purification was carried out on a nickel chelate affinity resin under denaturating conditions in guanidine hydrochloride buffers. Among all the conditions tested (pHs ranging from 5 to 9 and detergents such as Triton X-100, Nonidet P-40, and Tween 80), the only condition under which this protein could be eluted without being precipitated in the column and remain soluble was in a 6 M guanidine hydrochloride buffer.
Immunogenicity of the Des protein after infection. Twenty serum samples from M. tuberculosis-infected human patients (4 with extrapulmonary tuberculosis, 15 with pulmonary tuberculosis, and 1 with both forms of the disease), 6 sera from tuberculous M. bovis-infected human patients, and 4 sera from tuberculous M. bovis-infected cattle were either pooled or used individually in immunoblot experiments to determine the frequency of recognition of the purified Des protein by antibodies from infected humans and cattle. All 20 sera from tuberculous M. tuberculosis-infected human patients and all 6 sera from tuberculous M. bovis-infected human patients recognized the recombinant antigen, as shown by the reaction with the 37-kDa band (Fig. 4) . Furthermore, a pool of sera from human lepromatous leprosy patients also reacted with the Des antigen (Fig.  4) . In contrast, the pool of serum specimens from tuberculous 
DISCUSSION
The phoA gene fusion methodology permitted the identification of a new possibly exported M. tuberculosis antigenic protein with homologies to plant stearoyl-ACP desaturases. These enzymes are also exported proteins, as they are translocated across chloroplastic membranes (18) . Since no signal sequence could be identified in the N-terminal sequence of the Des protein, it is probable that Des is exported not via the general secretory pathway but through another export system. Alternate export systems that do not involve the cleavage of a classical N-terminal signal sequence have already been described for gram-negative and gram-positive bacteria. The Bacillus subtilis autolysins are exported to the cell wall through an unknown export system. The secreted Yersinia virulence determinants, Yops, are exported via a type III secretion pathway. Such alternate export systems might exist in mycobacteria, and the Des protein might be exported through one of them. Des is a 37-kDa protein containing conserved amino acid residues which are characteristic of class II diiron-oxo proteins. All the proteins from that family are enzymes that require iron for activity. They include ribonucleotide reductases, hydrocarbon   FIG. 3 . Southern blot analysis of the distribution of the des gene in other mycobacterial species. DNAs from the indicated mycobacterial strains were PstI digested, electrophoresed, transferred onto a nylon membrane by Southern blotting, and hybridized with probe B (Fig. 1) . hydroxylases, and stearoyl-ACP desaturases. The M. tuberculosis Des protein has significant homologies only to plant stearoyl-ACP desaturases (44% identity at the nucleotide level and 30% identity at the amino acid level). Desaturases catalyze the introduction of double bonds into fatty acid carbon chains; this suggests that the Des protein could be involved in mycobacterial fatty acid biosynthesis. Furthermore, the localization of this protein outside the cytoplasm would be consistent with its role in lipid metabolism, since lipids represent 60% of cell wall constituents and the biosynthesis of voluminous mycolic acids which contain 60 to 90 carbon atoms occurs there (20) . Among all the steps of lipid metabolism, desaturation reactions are of special interest because they often take place at early steps of lipid and mycolic acid biosynthesis and because they contribute to the adaptation of mycobacteria to their environment through the control they have on the unsaturation rate of membranes (37) . An enzyme system involving a stearoyl-coenzyme A desaturase (analog of plant stearoyl-ACP desaturases) that catalyzes oxidative desaturation of coenzyme A derivatives of stearic and palmitic acids to the corresponding ⌬9 monounsaturated fatty acids has been biochemically characterized in M. phlei (9, 10, 16, 17) . This system was shown to be firmly bound to a membranous structure (10 However, no ⌬9 desaturating activity was detected. This result could be linked to several factors. First of all, with the recombinant Des protein mainly found in inclusion bodies, the proportion of active soluble enzyme in E. coli cytoplasm might be too low to detect activity. Secondly, the recombinant Des protein might not be properly expressed in E. coli and might lack posttranslational modifications. Furthermore, desaturation systems are multienzyme complexes that involve electron transport chains and numerous cofactors which are often difficult to render functional in vitro. Since E. coli and mycobacteria are very different in lipid metabolism, the M. tuberculosis recombinant ⌬9 desaturase might not encounter in E. coli all the cofactors and associated enzymes required for activity or might not interact properly with them. Moreover, some of the cofactors involved in the ⌬9 desaturation process of mycobacteria are unknown; therefore, they might be missing in the incubation medium.
However, if the Des protein is a desaturase, there is an amazing point concerning its primary sequence. Indeed, all the animal and fungal desaturases and the very few bacterial desaturases sequenced to date are integral membrane proteins and have been classified as a third class of diiron-oxo proteins on the basis of conserved histidine residues in their primary sequences (30) . Plant soluble acyl-ACP desaturases are the only desaturases to possess the type of primary sequence of class II diiron-oxo proteins (29) . The sequence similarities of the Des protein to plant acyl-ACP desaturases suggest that mycobacteria could possess in addition to the already known stearoyl-coenzyme A and lignoceroyl-coenzyme A desaturases (9, 19 ) that act on acyl-ACP substrates. This hypothesis is currently under investigation.
As shown by immunoblotting and ELISA experiments, the Des protein is a highly immunogenic antigen which elicited B-cell responses in 100% of the tuberculous M. bovis-and M. tuberculosis-infected human patients tested, independently of the form of the disease (extrapulmonary or pulmonary). It also elicited an antibody response in lepromatous leprosy patients. Interestingly, although more sera need to be tested, tuberculous cattle did not seem to recognize the Des antigen. This result could be linked to differences in the human and cattle selection of the B-cell repertoire, antigen presentation, or accessory-cell function, such as T-cell help or active suppression. Furthermore, the results of ELISA experiments showed that it is possible to distinguish tuberculous patients from patients which suffer from other pathologies on the basis of the magnitude of the antibody response to the Des antigen. Nontuberculous BCG-vaccinated patients were chosen as controls because most tuberculosis cases occur in parts of the world where the population is BCG vaccinated. We thus wanted to check whether BCG vaccination (BCG expressing the Des protein) did not hamper the value of the Des antigen for discriminating between tuberculous and nontuberculous patients. Actually, BCG vaccination could explain why nontuberculous patients recognized the Des protein at a low level. This could also be due to cross-reactivity of their antibody response with other bacterial antigens. Large-scale studies of great numbers of nontuberculous and tuberculous human immunodeficiency virus (HIV)-positive and HIV-negative patients at different stages of the disease are needed in order to determine the reference cutoff of the ELISA between positive and negative patients. Once this cutoff is defined, it will be possible to calculate the specificity and sensitivity of the Des antigenbased serological test and to compare them with the results previously obtained with other antigens of proteinic (such as the 19-and 38-kDa antigens) and nonproteinic (DAT, PGLTb1, and lipooligosaccharide) natures. Furthermore, such large-scale studies will be useful in investigating whether the Des antigen specifically detects infections caused by the M. tuberculosis complex or whether patients that suffer from atypical mycobacteremia (including M. avium-infected patients) also recognize the M. tuberculosis Des antigen. In the latter case, specifically detecting M. tuberculosis infections will be dependent on finding within the Des protein epitopes specific to M. tuberculosis. However, from the preliminary results presented here, the Des antigen seems to be a good candidate for the serodiagnosis of tuberculosis in human patients. No pro- teinic antigen has yet been proved to be fully satisfactory since their value in serodiagnosis has been quite variable according to the study (4) and the class of tuberculous patients considered (smear positive or smear negative, children or adults, pulmonary or extrapulmonary tuberculosis, etc.) (5) . Nonproteinic antigens, such as the lipooligosaccharide antigen, gave interesting preliminary results in HIV patients (7). However, proteinic antigens which can be expressed as recombinant proteins in E. coli have the advantages of being purified more easily and in greater quantities than are nonproteinic antigens.
It would be interesting to determine whether the Des antigen possesses in addition to its B-cell epitopes T-cell epitopes, which are the only protective ones in the host immunological response against pathogenic mycobacteria. If the Des protein is also a good stimulator of the T-cell response in a majority of tuberculosis patients, it could be used either individually or as part of a cocktail of antigens in the design of a subunit vaccine against tuberculosis.
